Total Payments
$9,918
2024 Payments
$3,118
Companies
31
Transactions
572
Medicare Patients
1,544
Medicare Billing
$87,610
Payment Breakdown by Category
Food & Beverage$9,065 (91.4%)
Education$852.07 (8.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,065 | 559 | 91.4% |
| Education | $852.07 | 13 | 8.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,384 | 100 | $0 (2024) |
| Janssen Biotech, Inc. | $1,195 | 53 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,187 | 71 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $796.04 | 70 | $0 (2024) |
| Lilly USA, LLC | $666.15 | 35 | $0 (2024) |
| Incyte Corporation | $562.41 | 26 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $472.57 | 29 | $0 (2024) |
| UCB, Inc. | $377.03 | 17 | $0 (2024) |
| PFIZER INC. | $320.94 | 20 | $0 (2024) |
| LEO Pharma Inc. | $320.54 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,118 | 170 | ABBVIE INC. ($332.65) |
| 2023 | $3,137 | 173 | ABBVIE INC. ($460.65) |
| 2022 | $2,314 | 137 | ABBVIE INC. ($402.84) |
| 2021 | $1,349 | 92 | Janssen Biotech, Inc. ($291.68) |
All Payment Transactions
572 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $37.86 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: Immunology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $2.34 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.55 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $2.15 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.57 | General |
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Immunology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.15 | General |
| Category: Immunology | ||||||
| 11/11/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $36.04 | General |
| Category: Inflammation & Immunology | ||||||
| 11/11/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: DERMATOLOGY | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $54.99 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.96 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 741 | 1,252 | $106,475 | $43,177 |
| 2022 | 14 | 774 | 1,324 | $104,149 | $43,015 |
| 2021 | 1 | 18 | 18 | $2,430 | $990.91 |
| 2020 | 1 | 11 | 11 | $990.00 | $426.67 |
Total Patients
1,544
Total Services
2,605
Medicare Billing
$87,610
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 193 | 302 | $29,294 | $14,135 | 48.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 100 | 155 | $25,110 | $9,792 | 39.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 79 | 79 | $10,665 | $4,571 | 42.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 85 | 97 | $14,065 | $4,522 | 32.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 109 | 135 | $12,825 | $3,898 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 31 | $4,371 | $2,165 | 49.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 72 | 368 | $3,312 | $1,506 | 45.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 41 | 41 | $3,895 | $1,223 | 31.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 25 | $1,475 | $799.61 | 54.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 16 | 19 | $1,463 | $566.33 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 150 | 234 | $22,698 | $12,420 | 54.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 81 | 110 | $17,820 | $6,807 | 38.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 114 | 114 | $15,390 | $6,400 | 41.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 87 | 93 | $13,485 | $4,484 | 33.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 94 | 130 | $12,350 | $3,765 | 30.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 81 | 81 | $7,695 | $2,907 | 37.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 63 | 404 | $3,636 | $1,651 | 45.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $3,225 | $1,320 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 15 | $2,115 | $1,181 | 55.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 21 | $1,239 | $731.36 | 59.0% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2022 | 13 | 13 | $2,288 | $679.59 | 29.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 12 | 14 | $1,078 | $426.35 | 39.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 22 | $550.00 | $194.74 | 35.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 18 | 58 | $580.00 | $47.87 | 8.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $2,430 | $990.91 | 40.8% |
About Sarah Hirschman
Sarah Hirschman is a Physician Assistant healthcare provider based in Mt Pleasant, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/04/2014. The National Provider Identifier (NPI) number assigned to this provider is 1629491113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Hirschman has received a total of $9,918 in payments from pharmaceutical and medical device companies, with $3,118 received in 2024. These payments were reported across 572 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($9,065).
As a Medicare-enrolled provider, Hirschman has provided services to 1,544 Medicare beneficiaries, totaling 2,605 services with total Medicare billing of $87,610. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Mt Pleasant, MI
- Active Since 02/04/2014
- Last Updated 09/28/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1629491113
Products in Payments
- TREMFYA (Drug) $937.49
- TALTZ (Drug) $596.83
- SKYRIZI (Biological) $569.66
- RINVOQ (Biological) $542.52
- DUPIXENT (Biological) $478.27
- Sotyktu (Drug) $472.57
- OPZELURA (Drug) $463.42
- ILUMYA (Biological) $412.52
- COSENTYX (Biological) $397.42
- COSENTYX (Drug) $364.94
- REMICADE (Biological) $339.71
- Otezla (Drug) $302.21
- EUCRISA (Drug) $269.63
- Winlevi (Drug) $267.02
- ADBRY (Biological) $261.76
- VTAMA (Drug) $248.66
- Cimzia (Drug) $213.48
- HUMIRA (Biological) $177.92
- Bimzelx (Biological) $163.55
- Zoryve (Drug) $144.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Mt Pleasant
Ms. Allison Lester, Pa-C, PA-C
Physician Assistant — Payments: $151,100
Physician Assistant $151,100
Mrs. Louisa Floyd, Pa-C, PA-C
Physician Assistant — Payments: $7,142
Physician Assistant $7,142
Wyvette Leoni, Pa-C, PA-C
Physician Assistant — Payments: $6,432
Physician Assistant $6,432
Mrs. Lindsay Miller, Pa, PA
Physician Assistant — Payments: $3,879
Physician Assistant $3,879
Holly Carter, Pa-C, PA-C
Physician Assistant — Payments: $3,680
Physician Assistant $3,680
Mr. Christopher Horrell, Pa-C, PA-C
Physician Assistant — Payments: $3,623
Physician Assistant $3,623